1/3

FIEO Registered Export Ready

Enteric Coated Rabeprazole Sodium and Levosulpiride Sustained Release Capsules CRAB-LSR 10x10 Capsules

Name: Enteric Coated Rabeprazole Sodium and Levosulpiride Sustained Release Capsules CRAB-LSR 10x10 Capsules
Brand: cd&m remedies
SKU: 8644376
Availability: InStoreOnly

Sold by cd and m remedies private limited · Contractor, Distributor, Wholesaler · Kanpur, Uttar Pradesh, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HSN Code

300490

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for cd and m remedies private limited.

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Kanpur Dispatch on request FIEO member

cd and m remedies private limited

Contractor, Distributor, Wholesaler · Kanpur, Uttar Pradesh, India

we are currently a wholesale price distributor based in India . we can supply any and all allopathic drugs and also are involved in taking your valuable manufacturing orders for all tablets, capsules, injections, syrups. our focus is to give our best service to people through export and we work hard for our customers.

Registered address: Kanpur Nagar, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Other.

View profile All products

Established

2016

Employees

1–10

GST

09AAGCC4412K1ZN

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Aug 2025

Turnover

$250,000 - $1 MM

Incorporation Type

On request

Certifications & Awards

DRUG LICENSE GST IMPORT EXPORT CERTIFICATE

Product details

What are the specifications of this product?

Overview

Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr is a pharmacopeia-grade capsules formulation manufactured by CD&M Remedies, containing Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release). Formulated to Indian Pharmacopoeia (IP) specifications, this PPI prokinetic combination capsule is supplied in 10x10 Capsules export packing suitable for international wholesale and distribution. The product is positioned for B2B buyers seeking a reliable acid reflux and motility disorder medication for institutional, hospital, or retail pharmacy supply chains. CD&M Remedies maintains consistent batch-to-batch quality control, making this enteric-coated levosulpiride rabeprazole formulation a dependable addition to a pharmaceutical importer's product portfolio.Features:Composition: Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release)Manufactured to Indian Pharmacopoeia (IP) standards for consistent qualityAvailable in capsules form for ease of storage, handling, and dispensingSupplied by CD&M Remedies, an established pharmaceutical manufacturer and exporterExport-ready 10x10 Capsules packing designed for bulk international shipmentSuitable for wholesale distribution to pharmacies, hospitals, and healthcare institutionsAttributes:Brand / Seller: CD&M RemediesProduct Category: Gastrointestinal Medication (PPI + Prokinetic Combination)Dosage Form: CapsulesPack Size: 10x10 CapsulesPharmacopeial Standard: Indian Pharmacopoeia (IP)Product Code: 1017

Product Description

Product Overview

This formulation combines enteric-coated Rabeprazole Sodium with sustained-release Levosulpiride, intended for management of gastroesophageal reflux and related motility disorders.

Composition & Specifications

Each unit of this PPI prokinetic combination capsule contains Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release), formulated in capsules form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating acid reflux and motility disorder medication for their regional markets.

Application & Usage

Used in the management of acid-peptic and gastric motility disorders as directed by a physician. Suitable for supply to pharmacies, gastroenterology clinics, and hospitals.

Packaging & Export Readiness

Supplied in 10x10 blister strips, designed to preserve capsule integrity during international export. The 10x10 Capsules configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing enteric-coated levosulpiride rabeprazole formulation in bulk quantities.

Why Source From CD&M Remedies

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying PPI prokinetic combination capsule to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: It contains Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release), manufactured to Indian Pharmacopoeia (IP) standards in capsules form.

Q: What pack sizes are available for Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: This product is supplied in 10x10 Capsules export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr?
A: Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr is manufactured and supplied by CD&M Remedies, under product code 1017.

Q: Which product category does Enteric Coated Rabeprazole Sodium And Levosulpiride Sustained Release Capsules Crab-Lsr belong to?
A: It falls under the Gastrointestinal Medication (PPI + Prokinetic Combination) category, intended for B2B pharmaceutical buyers and importers.

Description provided by cd and m remedies private limited.

Specifications

Product Name	Enteric Coated Rabeprazole Sodium and Levosulpiride Sustained Release Capsules CRAB-LSR 10x10 Capsules
Brand / Seller	CD AND M REMEDIES PRIVATE LIMITED
Product Code	1017
Category	Gastrointestinal Medication (PPI + Prokinetic Combination)
Dosage Form	Capsules
Composition	Rabeprazole Sodium IP 20 mg (enteric coated) + Levosulpiride 75 mg (sustained release)
Pharmacopeial Standard	Indian Pharmacopoeia (IP)
Pack Size	10x10 Capsules
Packaging Type	Export packing / blister strip packing
MOQ	1
Intended Use	Management of gastroesophageal reflux and related motility disorders
Supply Channel	Wholesale, institutional, export

Use cases

Category	Gastrointestinal Medication Capsules
Primary application	Wholesale, distribution, and international sourcing
Brand	cd&m remedies
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Enteric Coated Rabeprazole Sodium and Levosulpiride Sustained Release Capsules CRAB-LSR 10x10 Capsules. Answers compiled from verified sellers' commercial terms and platform data.

Q: What is the exact composition of CRAB-LSR capsules?

A: Each capsule contains Rabeprazole Sodium IP 20 mg in enteric-coated form and Levosulpiride 75 mg in sustained-release form.

Q: What pharmacopeial standard does this formulation follow?

A: The product is manufactured to Indian Pharmacopoeia (IP) specifications.

Q: What is the pack size for wholesale supply?

A: The capsules are supplied in 10x10 Capsules export packing.

Q: Is this product suitable for export and institutional procurement?

A: Yes, it is supplied in export-ready packing and is positioned for wholesale distribution to pharmacies, hospitals, and healthcare institutions.

Q: What is the intended therapeutic use of this capsule formulation?

A: It is used in the management of gastroesophageal reflux and related motility disorders as directed by a physician.

Q: Who manufactures this product?

A: It is manufactured and supplied by CD AND M REMEDIES PRIVATE LIMITED.